Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Company News
Events
Directory
Search
Close search
Home
Company
Mundipharma International
Mundipharma International
Activities:
Research & Development
X
LinkedIn
Trending Articles
Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222
Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
CordenPharma & GENEPEP collaborate to leverage peptide drug substance discovery
The partnership has facilitated the expedition of the development, discovery and manufacturing of peptides for early clinical phase
ISPE announces 2024 Facility of the Year Awards category winners
The awards programme recognises pharmaceutical companies that are the 'best' in the industry for innovation, operations, digitalisation, supply chain and social impact
Tabletability, compactability and compressibility: What’s the difference?
To patients and consumers, tablets are a simple and convenient dosage form, but the science behind compressing a block of particles or granules into a single tablet can be...
Chemistry, manufacturing and control (CMC) as key drivers for drug discovery success
Embracing collaborative strategies not only accelerates drug development programmes but also fosters science-based milestone decisions, mitigates risks and prepares for...
Upcoming event
Making Pharmaceuticals
23–24 April 2024 | Exhibition | Coventry, UK
See all
Related Content
Ingredients
Helsinn brings cancer pain management option to China
With the help of Mundipharma China Pharmaceutical, ALOXI IV will be used for the prevention of chemotherapy-induced nausea and vomiting (CINV) in China
Media
Grunenthal and Mundipharma enter commercial partnership in China
Grünenthal and Mundipharma announced they have entered into a License and Distribution Agreement
Media
Mundipharma and CellAct announce deal for development of smart chemo
CellAct has provided the Mundipharma network, of independent associated companies, the worldwide development, commercialisation and manufacturing rights to CAP7.1
Distribution
Mundipharma partners with Munir Sukhtian Group to strengthen its consumer healthcare business
Partnership to increases access to the HiGeen range of products for millions of people across the Middle East and Africa region
Research & Development
Mundipharma Laboratories and Purdue Pharma enter global partnership with Laboratorios Esteve
To drive innovation in pain management
Subscribe now